In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including...
High risk for psychiatric disorders seen before dementia diagnosis
Oct 20, 2023
The findings were consistent regardless of dementia subtype.
Medicare spending spikes for dementia diagnoses in seniors
Jun 13, 2022
Medicare spending was higher for adults with a formal clinical diagnosis of dementia versus a positive screening for cognitive impairment.
Patients with dementia less likely to receive intensive care after hospital transfer
Jan 04, 2024
The authors say that future work should focus on determining whether transfers are needed.
Composite inflammatory biomarker linked to dementia risk
Jul 21, 2023
Small but significant associations were seen between elevated biomarker levels and worsened cognitive performance.
Changes in movement may indicate preclinical Alzheimer’s disease
Jul 02, 2021
Changes in daytime fractal motor activity regulation may occur in women before cognitive symptoms of Alzheimer’s disease.
Earlier onset of A-Fib linked to risk of developing all-cause dementia
Nov 10, 2023
Younger age at A-Fib onset was linked to increased risks of all-cause and vascular dementia and Alzheimer disease.
Stress, depression linked to MCI, Alzheimer’s disease
Oct 20, 2023
Chronic stress and depression are independent risk factors and have an additive effect when combined.
Panel of 48 CSF proteins complements existing Alzheimer’s biomarkers
Sep 07, 2023
The CSF 48 panel plus existing biomarkers significantly improved the diagnostic performance for the outcomes studied.
Alzheimer’s disease, related dementia diagnoses up in Medicare decedents
Apr 01, 2022
The percentage of older U.S. decedents with a diagnosis of Alzheimer’s disease and related dementias increased significantly from 2004 to 2017.